Tag: Department of Psychiatry October 7, 2021 $12.2 million to fund new Conte Center to study neurosteroidsComplements efforts of Taylor Family Institute to develop treatments for psychiatric illness.News Release July 8, 2021 New Alzheimer’s treatment targets identifiedStudy points to FDA-approved drugs that have potential to slow or reverse brain damage.News Release March 2, 2021 Opioid overdose reduced in patients taking buprenorphineStudy indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions .News Release November 12, 2020 Fluvoxamine may prevent serious illness in COVID-19 patientsAntidepressant drug repurposed for patients with coronavirus infection.News Release October 2, 2020 Sarafinovska honored for work to improve medical students’ mental healthNamed inaugural recipient of brAvery Foundation Award. October 2, 2020 Basis of developmental disabilities focus of $11.3 million in grantsResearch to examine genetic, environmental factors linked to such disabilities and how to improve lives of those affected.News Release May 26, 2020 $13.7 million to further adolescent brain development studyGrant from National Institute on Drug Abuse to extend landmark study.News Release August 14, 2019 Genes linked to Alzheimer’s risk, resilience ID’dGenes in the brain’s immune cells may point to strategy to protect against the disease.News Release July 17, 2019 More cancer patients get help to quit smokingSiteman Cancer Center expands smoking-cessation efforts.News Release April 10, 2019 $10 million gift aimed at improving treatments for mental illnessDepression is primary focus of research.News Release Posts navigation ‹ Prev 1 2
